Izolde Bouloukaki

Dr. Izolde Bouloukaki

Sleep Medicine, School of Medicine, University of Crete, Greece, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2014 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
KGKaterina Giannadaki
Katerina Giannadaki
CMCharalampos Mermigkis
Charalampos Mermigkis
NTNikolaos Tzanakis
Nikolaos Tzanakis
EMEleni Mauroudi
Eleni Mauroudi
SSSophia E. Schiza
Sophia E. Schiza
We aimed to compare the effect of intensiveversusstandard interventions on continuous positive airway pressure (CPAP) adherence 2 years after CPAP initiation, as well as on sleepiness, quality of life, depression, hospitalisation and death rate due to cardiovascular disease (CVD).3100 patients with newly diagnosed sleep apnoea were randomised into the standard group, with usual follow-up care, or the intensive group, with additional visits, telephone calls and education. Subjective daytime sleepiness (Epworth Sleepiness Scale; ESS), quality of life (36-item Short Form Health Survey; SF-36) and the patient’s level of depression (Beck Depression Inventory; BDI) were recorded before and 2 years after CPAP initiation, together with CVD hospitalisations and death rate.2 years after CPAP initiation, the intensive group used CPAP significantly more than the standard group (6.9versus5.2 h per night; p<0.001). ESS, SF-36 and BDI scores were also significantly better in the intensive group. Furthermore, the standard group had significantly more deaths and hospitalisations due to CVD.CPAP usage can be improved by both intensive and standard patient support. However, the patients who received intensive CPAP support had significantly better ESS, BDI and SF-36 scores, and lower cardiovascular morbidity and mortality, suggesting that an intensive programme could be worthwhile.

31 July 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
CMCharalampos Mermigkis
Charalampos Mermigkis
NTNikolaos Tzanakis
Nikolaos Tzanakis
EKEleftherios Kallergis
Eleftherios Kallergis
VMVioleta Moniaki
Violeta Moniaki
SSSophia Schiza
Sophia Schiza
Systemic inflammation is important in obstructive sleep apnea (OSA) pathophysiology and its comorbidity. We aimed to assess the levels of inflammatory biomarkers in a large sample of OSA patients and to investigate any correlation between these biomarkers with clinical and polysomnographic (PSG) parameters. This was a cross-sectional study in which 2983 patients who had undergone a polysomnography for OSA diagnosis were recruited. Patients with known comorbidities were excluded. Included patients (n=1053) were grouped according to apnea-hypopnea index (AHI) as mild, moderate, and severe. Patients with AHI < 5 served as controls. Demographics, PSG data, and levels of high-sensitivity C-reactive protein (hs-CRP), fibrinogen, erythrocyte sedimentation rate (ESR), and uric acid (UA) were measured and compared between groups. A significant difference was found between groups in hs-CRP, fibrinogen, and UA. All biomarkers were independently associated with OSA severity and gender (p<0.05). Females had increased levels of hs-CRP, fibrinogen, and ESR (p<0.001) compared to men. In contrast, UA levels were higher in men (p<0.001). Our results suggest that inflammatory markers significantly increase in patients with OSA without known comorbidities and correlate with OSA severity. These findings may have important implications regarding OSA diagnosis, monitoring, treatment, and prognosis. This trial is registered with ClinicalTrials.gov numberNCT03070769.

15 June 2020 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
LGLudger Grote
Ludger Grote
WMWalter T. McNicholas
Walter T. McNicholas
JHJan Hedner
Jan Hedner
JVJohan Verbraecken
Johan Verbraecken
ONOn Behalf Of The European Sleep Apnoea Database Network
On Behalf Of The European Sleep Apnoea Database Network
Study Objectives:The association of mild obstructive sleep apnoea (OSA) with important clinical outcomes remains unclear. We aimed to investigate the association between mild OSA and systemic arter...

25 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
ITIoanna Tsiligianni
Ioanna Tsiligianni
GSGeorgios Stathakis
Georgios Stathakis
MFMichail Fanaridis
Michail Fanaridis
AKAthina Koloi
Athina Koloi
SSSophia Schiza
Sophia Schiza
The aim of our study was to assess university students’ sleep quality and fatigue before and during the academic exam period and identify potential associated factors. A Web-based survey was completed by 940 students of 20 different Tertiary Institutions including demographics, sleep habits, exercise, caffeine, tobacco, alcohol use, subjective sleep quality (Pittsburgh Sleep Quality Index—PSQI), and fatigue (Fatigue severity scale—FSS) at the beginning of the semester and during the examination period. During the exam period, PSQI (8.9 vs. 6.1, p < 0.001) and FSS scores (36.9 vs. 32.7, p < 0.001) were significantly elevated compared to the pre-exam period. An increase in the PSQI score was associated with age (β = 0.111, p = 0.011), presence of chronic disease (β = 0.914, p = 0.006), and depressive symptoms (β = 0.459, p = 0.001). An increase in the FSS score was associated with female gender (β = 1.658, p < 0.001), age, (β = 0.198, p = 0.010), increase in smoking (β = 1.7, p = 0.029), coffee/energy drinks consumption (β = 1.988, p < 0.001), decreased levels of physical exercise (β = 1.660, p < 0.001), and depressive symptoms (β = 2.526, p < 0.001). In conclusion, our findings indicate that exam periods have a negative impact on the sleep quality and fatigue levels of university students. Potential factors were identified that could contribute to the formulation of strategies for improved sleep quality and wellness.

24 January 2013 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
IKIoannis D Komninos
Ioannis D Komninos
CMCharalampos Mermigkis
Charalampos Mermigkis
KMKaterina Micheli
Katerina Micheli
MKMaria Komninou
Maria Komninou
SSSophia Schiza
Sophia Schiza
The aim of our study was to validate a Greek translation of the Berlin Questionnaire (BQ) for obstructive sleep apnoea syndrome (OSAS) and to explore whether this screening questionnaire could be used to help identify primary care patients at greater risk of having OSAS.

1 March 2021 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
GPGeorge Papadogiannis
George Papadogiannis
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
CMCharalampos Mermigkis
Charalampos Mermigkis
SMStylianos Michelakis
Stylianos Michelakis
CEChristina Ermidou
Christina Ermidou
SSSophia E. Schiza
Sophia E. Schiza
Study Objectives:Obstructive sleep apnea (OSA) in patients with idiopathic pulmonary fibrosis (IPF) is associated with worse mortality and clinical outcome. We aimed to assess differences between p...